University of Hertfordshire

From the same journal

By the same authors

Feasibility trial of cognitive behavioural therapy for fatigue in haemodialysis (BReF intervention)

Research output: Contribution to journalArticlepeer-review

Standard

Feasibility trial of cognitive behavioural therapy for fatigue in haemodialysis (BReF intervention). / Picariello, Federica; Moss-Morris, Rona; Norton, Sam; Macdougall, Iain C; Da Silva-Gane, Maria; Farrington, Ken; Clayton, Hope; Chilcot, Joseph.

In: Journal of Pain and Symptom Management, 14.10.2020.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Picariello, Federica ; Moss-Morris, Rona ; Norton, Sam ; Macdougall, Iain C ; Da Silva-Gane, Maria ; Farrington, Ken ; Clayton, Hope ; Chilcot, Joseph. / Feasibility trial of cognitive behavioural therapy for fatigue in haemodialysis (BReF intervention). In: Journal of Pain and Symptom Management. 2020.

Bibtex

@article{fc20f484950746d8ad691c97646707e5,
title = "Feasibility trial of cognitive behavioural therapy for fatigue in haemodialysis (BReF intervention)",
abstract = "OBJECTIVE: Fatigue affects at least half of patients who are on haemodialysis with considerable repercussions on their functioning, quality of life, and clinical outcomes. This study assessed the feasibility, acceptability, and potential benefits of a cognitive-behavioural therapy (CBT) intervention for fatigue (BReF intervention).METHODS: This was a feasibility randomised-controlled trial of the BReF intervention versus waiting-list control. Outcomes included recruitment, retention, and adherence rates. Exploratory estimates of treatment effect were computed. The statistician was blinded to allocation.RESULTS: Twenty-four prevalent haemodialysis patients experiencing clinical levels of fatigue were individually randomised (1:1) to BReF (N=12) or waiting-list control arms (N=12). 53 (16.6% 95% CI 12.7% to 21.1%) out of 320 patients approached consented and completed the screening questionnaire. It was necessary to approach 13 patients for screening for every 1 patient randomised. The rate of retention at follow-up was 75% (95% CI 53.29% to 90.23%). Moderate to large treatment effects were observed in favour of BReF on fatigue severity, fatigue-related functional impairment, depression, and anxiety SMDg=0.81, SMDg=0.93, SMDg=0.38, SMDg=0.42, respectively), but not sleep quality (SMDg=-0.31). No trial adverse events occurred.CONCLUSION: There was promising evidence in support of the need and benefits of a CBT-based intervention for fatigue in haemodialysis. However, uptake was low, possibly as a result of an already high treatment burden in this setting. Considerations on the context of delivery are necessary before pursuing a definitive trial.",
author = "Federica Picariello and Rona Moss-Morris and Sam Norton and Macdougall, {Iain C} and {Da Silva-Gane}, Maria and Ken Farrington and Hope Clayton and Joseph Chilcot",
note = "{\textcopyright} 2020 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/.",
year = "2020",
month = oct,
day = "14",
doi = "10.1016/j.jpainsymman.2020.10.005",
language = "English",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Feasibility trial of cognitive behavioural therapy for fatigue in haemodialysis (BReF intervention)

AU - Picariello, Federica

AU - Moss-Morris, Rona

AU - Norton, Sam

AU - Macdougall, Iain C

AU - Da Silva-Gane, Maria

AU - Farrington, Ken

AU - Clayton, Hope

AU - Chilcot, Joseph

N1 - © 2020 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2020/10/14

Y1 - 2020/10/14

N2 - OBJECTIVE: Fatigue affects at least half of patients who are on haemodialysis with considerable repercussions on their functioning, quality of life, and clinical outcomes. This study assessed the feasibility, acceptability, and potential benefits of a cognitive-behavioural therapy (CBT) intervention for fatigue (BReF intervention).METHODS: This was a feasibility randomised-controlled trial of the BReF intervention versus waiting-list control. Outcomes included recruitment, retention, and adherence rates. Exploratory estimates of treatment effect were computed. The statistician was blinded to allocation.RESULTS: Twenty-four prevalent haemodialysis patients experiencing clinical levels of fatigue were individually randomised (1:1) to BReF (N=12) or waiting-list control arms (N=12). 53 (16.6% 95% CI 12.7% to 21.1%) out of 320 patients approached consented and completed the screening questionnaire. It was necessary to approach 13 patients for screening for every 1 patient randomised. The rate of retention at follow-up was 75% (95% CI 53.29% to 90.23%). Moderate to large treatment effects were observed in favour of BReF on fatigue severity, fatigue-related functional impairment, depression, and anxiety SMDg=0.81, SMDg=0.93, SMDg=0.38, SMDg=0.42, respectively), but not sleep quality (SMDg=-0.31). No trial adverse events occurred.CONCLUSION: There was promising evidence in support of the need and benefits of a CBT-based intervention for fatigue in haemodialysis. However, uptake was low, possibly as a result of an already high treatment burden in this setting. Considerations on the context of delivery are necessary before pursuing a definitive trial.

AB - OBJECTIVE: Fatigue affects at least half of patients who are on haemodialysis with considerable repercussions on their functioning, quality of life, and clinical outcomes. This study assessed the feasibility, acceptability, and potential benefits of a cognitive-behavioural therapy (CBT) intervention for fatigue (BReF intervention).METHODS: This was a feasibility randomised-controlled trial of the BReF intervention versus waiting-list control. Outcomes included recruitment, retention, and adherence rates. Exploratory estimates of treatment effect were computed. The statistician was blinded to allocation.RESULTS: Twenty-four prevalent haemodialysis patients experiencing clinical levels of fatigue were individually randomised (1:1) to BReF (N=12) or waiting-list control arms (N=12). 53 (16.6% 95% CI 12.7% to 21.1%) out of 320 patients approached consented and completed the screening questionnaire. It was necessary to approach 13 patients for screening for every 1 patient randomised. The rate of retention at follow-up was 75% (95% CI 53.29% to 90.23%). Moderate to large treatment effects were observed in favour of BReF on fatigue severity, fatigue-related functional impairment, depression, and anxiety SMDg=0.81, SMDg=0.93, SMDg=0.38, SMDg=0.42, respectively), but not sleep quality (SMDg=-0.31). No trial adverse events occurred.CONCLUSION: There was promising evidence in support of the need and benefits of a CBT-based intervention for fatigue in haemodialysis. However, uptake was low, possibly as a result of an already high treatment burden in this setting. Considerations on the context of delivery are necessary before pursuing a definitive trial.

U2 - 10.1016/j.jpainsymman.2020.10.005

DO - 10.1016/j.jpainsymman.2020.10.005

M3 - Article

C2 - 33068707

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

ER -